(OPRX) |
| 0 (0%) 10-10 16:16 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 20.70 |
| Resistance 1: | 19.31 |
| Pivot price: | 18.69 |
| Support 1: | 17.05 |
| Support 2: | 14.19 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.540 |
| Book Value | 6.430 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.632 |
| Profit Margin (%) | -9.42 |
| Operating Margin (%) | 10.92 |
| Return on Assets (ttm) | 1.3 |
| Return on Equity (ttm) | -8.2 |
Company news
Fri, 10 Oct 2025
Citizens JMP Maintains OptimizeRx(OPRX.US) With Buy Rating, Raises Target Price to $23 - 富途牛牛
Fri, 10 Oct 2025
New Analyst Forecast: $OPRX Given 'Market Outperform' Rating - Quiver Quantitative
Fri, 10 Oct 2025
Understanding OPRX’s price movement - July 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Fri, 10 Oct 2025
OptimizeRX price target raised to $23 from $20 at Citizens - Investing.com
Tue, 07 Oct 2025
OptimizeRx: How The Stock Is Changing Pharma Marketing (NASDAQ:OPRX) - Seeking Alpha
Tue, 07 Oct 2025
Insider Sale: Chief Executive Officer of $OPRX Sells 1,620 Shares - Quiver Quantitative
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
